MPPE1 and cancer: Moreover, cDC1 are rare because TME excludes cDC1 from tumors through various mechanisms.10 Thus, approaches aimed to enhance antigen presentation, including increasing cDC1 activation and tumor infiltration may therefore promote antitumor immunity and improve cancer immunotherapy.